COMP <GO>
MSA vs LLY // PIOTROSKI F-SCORE QUALITY
MSA Safety Incorporated (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: MSA 6
— LLY 9
▲ PIOTROSKI F-SCORE QUALITY LEADER: LLY
LAST: $178.57 (-0.33%) • MKT CAP: $6.91B
piotroski-score
7/9
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
piotroski-score
9/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MSA VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MSA | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.50% | 83.64% | -37.14 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.60% | 32.36% | -15.76 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 36.4x | -19.42 | MSA | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 2.30% | +1.97 | MSA | /fcf-yield <GO> |
| Operating Margin | 19.80% | 40.21% | -20.41 | LLY | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 31.90% | -17.00 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 45.51% | -41.81 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.19% | 0.49% | +0.70 | MSA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 9.29 | -3.46 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.77% | -0.27 | MSA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.1 | 77.9 | -33.80 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.51 | +0.36 | MSA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.1x | 26.3x | -3.15 | MSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.91B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MSA REV | LLY REV | MSA GROSS % | LLY GROSS % | MSA FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.87B | $65.18B | 46.5% | 83.0% | $295.4M | $16.81B |
| FY 2024 | $1.81B | $45.04B | 47.6% | 81.3% | $242.2M | $8.82B |
| FY 2023 | $1.79B | $34.12B | 44.0% | 79.3% | $12.4M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MSA // BETA 0.87
LLY // BETA 0.51